Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma

This study has suspended participant recruitment.
(Bexxar isn't being produced by the manufacturer as of Feb. 2014)
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Daniel Lebovic, M.D., University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT01389076
First received: July 5, 2011
Last updated: October 3, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)